Business Description
Marvel Biosciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA57384M1077
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | -3.45 | |||||
Debt-to-Equity | -0.61 | |||||
Debt-to-EBITDA | -0.62 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -25.3 | |||||
3-Year EPS without NRI Growth Rate | -27.4 | |||||
3-Year FCF Growth Rate | -26 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.17 | |||||
9-Day RSI | 38.87 | |||||
14-Day RSI | 38.25 | |||||
6-1 Month Momentum % | 80 | |||||
12-1 Month Momentum % | 42.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.43 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.35 | |||||
Days Payable | 306.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -341.72 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.09 | |||||
EV-to-EBITDA | -2.09 | |||||
EV-to-FCF | -3.69 | |||||
Earnings Yield (Greenblatt) % | -47.72 | |||||
FCF Yield % | -29.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.06 | ||
Beta | 0 | ||
Volatility % | 65.75 | ||
14-Day RSI | 38.25 | ||
14-Day ATR (C$) | 0.011671 | ||
20-Day SMA (C$) | 0.12775 | ||
12-1 Month Momentum % | 42.11 | ||
52-Week Range (C$) | 0.01 - 0.19 | ||
Shares Outstanding (Mil) | 39.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Marvel Biosciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(TSXV:MRVL)'s stock price today?
When is next earnings date of Marvel Biosciences Corp(TSXV:MRVL)?
Does Marvel Biosciences Corp(TSXV:MRVL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |